Across TCGA pan-cancer cohorts, LINC01139 RNA is linked to patient survival in 28 of 34 cancer types, making it the most broadly survival-associated LINC01139 data layer compared with 1 for mutation status.
The strongest signal is observed in bladder urothelial carcinoma (BLCA), where higher LINC01139 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated LINC01139 expression acts as an unfavorable survival marker, although some lineages such as UCS and CESC show a favorable association.
BLCA, UCEC, and UCS are the cancer types where LINC01139 RNA most reproducibly stratifies survival.
RNA survival associations by lineage
Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.